Korro Bio, Inc. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Korro Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Korro Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$23.3M, a 21.6% decline year-over-year.
  • Korro Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$95.8M, a 84.7% decline year-over-year.
  • Korro Bio, Inc. annual Operating Income (Loss) for 2023 was -$84.5M, a 43.3% decline from 2022.
  • Korro Bio, Inc. annual Operating Income (Loss) for 2022 was -$59M, a 29.8% increase from 2021.
  • Korro Bio, Inc. annual Operating Income (Loss) for 2021 was -$84M, a 205% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$84.5M -$25.5M -43.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 -$59M +$25M +29.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 -$84M -$56.5M -205% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 -$27.6M -$6.88M -33.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$20.7M -$1.73M -9.14% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 -$18.9M -$2.64M -16.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 -$16.3M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.